In addition, a recent study found that the percentage of CD3+ T cells was higher, but the percentage of CD4+ T cells was lower in PD patients treated with antiparkinson drugs than drug naïve (Kustrimovic et al., 2016). Here, CD4 is linked to Parkinson disease.